Embracing Bayesian Methods in Clinical Trials

JAMA 2026

View at publisher
Authors: J. Jack Lee, Frank E. Harrell, Lisa M. LaVange, David J. Spiegelhalter
DOI: 10.1001/jama.2026.4179
Cited by: 9
References: 5

Abstract

This Perspective discusses the importance of the US Food and Drug Administration’s draft guidance on the use of bayesian methods in clinical trials because it underscores its commitment to modernizing clinical research.

Fields of Study & Subjects

Statistical Methods in Clinical Trials Statistical Methods and Bayesian Inference Meta-analysis and systematic reviews

Publication details

Journal / source
JAMA
Publisher
American Medical Association (AMA)
Volume
335
Issue
19
Pages
1664–1664
Publication date
23 March 2026
Language
EN